A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index

Variation in brain monoaminergic activity is heritable and modulates risk of alcoholism and other addictions, as well as food intake and energy expenditure. Monoamine oxidase A deaminates the monoamine neurotransmitters serotonin, dopamine (DA), and noradrenalin. The monoamine oxidase A (MAOA) gene (Xp11.5) contains a length polymorphism in its promoter region (MAOA-LPR) that putatively affects transcriptional efficiency. Our goals were to test (1) whether MAOA-LPR contributes to interindividual variation in monoamine activity, assessed using levels of cerebrospinal fluid (CSF) monoamine metabolites; and (2) whether MAOA-LPR genotype influences alcoholism and/or body mass index (BMI). Male, unrelated criminal alcoholics (N=278) and controls (N=227) were collected from a homogeneous Finnish source population. CSF concentration of 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), and 3-methoxy-4-hydroxyphenylglycol (MHPG) were available from 208 participants. Single allele, hemizygous genotypes were grouped according to inferred effect of the MAOA alleles on transcriptional activity. MAOA-LPR genotypes had a significant effect on CSF HVA concentration (P=0.01) but explained only 3% of the total variance. There was a detectable but nonsignificant genotype effect on 5-HIAA and no effects on MHPG. Specifically, the genotype conferring high MAOA activity was associated with lower HVA levels in both alcoholics and controls, a finding that persisted after accounting for the potential confounds of alcoholism, BMI, height, and smoking. MAOA-LPR genotype predicted BMI (P<0.005), with the high-activity genotype being associated with lower BMI. MAOA-LPR genotypes were not associated with alcoholism or related psychiatric phenotypes in this data set. Our results suggest that MAOA-LPR allelic variation modulates DA turnover in the CNS, but does so in a manner contrary to our prior expectation that alleles conferring high activity would predict higher HVA levels in CSF. Our results are consistent with an emerging literature that suggests greater complexity in how variation in MAOA expression alters monoaminergic function. Finally, our work suggests that MAOA may be involved in the regulation of BMI. Independent samples are necessary to confirm this preliminary finding.

[1]  K. Nunn,et al.  Epistatic interaction between the monoamine oxidase A and serotonin transporter genes in anorexia nervosa , 2005, European Journal of Human Genetics.

[2]  Frederick K. Goodwin,et al.  Aggression in humans correlates with cerebrospinal fluid amine metabolites , 1979, Psychiatry Research.

[3]  G. Sedvall,et al.  Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study. , 1986, Journal of psychiatric research.

[4]  D. Hamer,et al.  A functional polymorphism in the monoamine oxidase A gene promoter , 1998, Human Genetics.

[5]  M. Meguid,et al.  Neuropeptide Y, alpha-melanocyte-stimulating hormone, and monoamines in food intake regulation. , 2005, Nutrition.

[6]  M. Linnoila,et al.  A prospective follow-up study of alcoholic violent offenders and fire setters. , 1996, Archives of general psychiatry.

[7]  Nora D Volkow,et al.  Similarity Between Obesity and Drug Addiction as Assessed by Neurofunctional Imaging , 2004, Journal of addictive diseases.

[8]  The Council on National Affairs , 1980 .

[9]  T. Maeda,et al.  Distribution of type B monoamine oxidase immunoreactivity in the cat brain with reference to enzyme histochemistry , 1991, Neuroscience.

[10]  Klaus-Peter Lesch,et al.  Monoamine oxidase A gene promoter variation and rearing experience influences aggressive behavior in rhesus monkeys , 2005, Biological Psychiatry.

[11]  S. McCarthy,et al.  MAOA haplotypes associated with thrombocyte-MAO activity , 2005, BMC Genetics.

[12]  Lisa J. Martin,et al.  Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid , 2004, Biological Psychiatry.

[13]  M. Owen,et al.  Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[14]  U. Pettersson,et al.  Investigation of the functional effect of monoamine oxidase polymorphisms in human brain , 2001, Human Genetics.

[15]  M. Scheinin,et al.  Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection. , 1983, Analytical biochemistry.

[16]  L. Oreland,et al.  Intra- and extra-dopamine-synaptosomal localization of monoamine oxidase in striatal homogenates from four species. , 1987, Biochemical pharmacology.

[17]  S. Paul,et al.  Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression. , 1986, The American journal of psychiatry.

[18]  K. Lesch,et al.  Cluster B Personality Disorders are Associated with Allelic Variation of Monoamine Oxidase A Activity , 2005, Neuropsychopharmacology.

[19]  M. Meguid,et al.  Neuropeptide Y, α-melanocyte–stimulating hormone, and monoamines in food intake regulation , 2005 .

[20]  K. Lesch,et al.  Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism , 1999, Psychiatry Research.

[21]  H. Nicolini,et al.  Family-Based Association Study between the Monoamine Oxidase A Gene and Obesity: Implications for Psychopharmacogenetic Studies , 2004, Neuropsychobiology.

[22]  J. Long,et al.  HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses , 1999, Biological Psychiatry.

[23]  R. A. Price,et al.  An X-chromosome scan reveals a locus for fat distribution in chromosome region Xp21-22. , 2002, Diabetes.

[24]  K. Pacak,et al.  Modification of cerebral cortical noradrenaline release by chronic inhibition of MAO-A. , 1994, Journal of neural transmission. Supplementum.

[25]  N. K. Dhingra,et al.  Role of Monoamine Oxidase Type A and B on the Dopamine Metabolism in Discrete Regions of the Primate Brain , 1998, Neurochemical Research.

[26]  K. Lesch,et al.  Different allele distribution of a regulatory MAOA gene promoter polymorphism in antisocial and anxious-depressive alcoholics , 2000, Journal of Neural Transmission.

[27]  J. Mann,et al.  Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa. , 1998, Archives of general psychiatry.

[28]  D. Goldman,et al.  Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in rhesus monkeys (Macaca mulatta). , 1993, Archives of general psychiatry.

[29]  M J Owen,et al.  A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. , 2000, Journal of psychiatric research.

[30]  W. J. Klein,et al.  Aggression, suicide, and serotonin: relationships to CSF amine metabolites. , 1982, The American journal of psychiatry.

[31]  P. Gaspar,et al.  Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. , 1995, Science.

[32]  M. Nöthen,et al.  Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. , 1999, Human molecular genetics.

[33]  R. Ebstein,et al.  Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA) , 2002, Molecular Psychiatry.

[34]  M. Fava,et al.  Weight gain and antidepressants. , 2000, The Journal of clinical psychiatry.

[35]  L. Eaves,et al.  Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. , 2004, Archives of general psychiatry.

[36]  R. Anthenelli,et al.  Monoamine oxidases and tobacco smoking. , 2001, The international journal of neuropsychopharmacology.

[37]  M. Nelen,et al.  Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. , 1993, Science.

[38]  B. Bondy,et al.  No association between a polymorphism in the promoter region of the MAOA gene with antisocial personality traits in alcoholics. , 2003, Alcohol and alcoholism.

[39]  C. Waternaux,et al.  Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. , 2003, The American journal of psychiatry.

[40]  J. Mann,et al.  An Association between a Functional Polymorphism in the Monoamine Oxidase A Gene Promoter, Impulsive Traits and Early Abuse Experiences , 2004, Neuropsychopharmacology.

[41]  G. Zalsman,et al.  Relationship of MAO‐A promoter (u‐VNTR) and COMT (V158M) gene polymorphisms to CSF monoamine metabolites levels in a psychiatric sample of caucasians: A preliminary report , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[42]  Jean Logan,et al.  Brain dopamine and obesity , 2001, The Lancet.

[43]  D. Goldman,et al.  Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence. , 1995, Journal of psychiatry & neuroscience : JPN.

[44]  C. Nemeroff,et al.  Are mood disorders and obesity related? A review for the mental health professional. , 2004, The Journal of clinical psychiatry.

[45]  J. Flory,et al.  A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity , 2000, Psychiatry Research.

[46]  A. Caspi,et al.  Role of Genotype in the Cycle of Violence in Maltreated Children , 2002, Science.

[47]  R. Neve,et al.  Tissue Distribution of Human Monoamine Oxidase A and B mRNA , 1990, Journal of neurochemistry.

[48]  M. Nelen,et al.  X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. , 1993, American journal of human genetics.

[49]  K. Gadde,et al.  Serotonin-Related Gene Polymorphisms and Central Nervous System Serotonin Function* , 2003, Neuropsychopharmacology.

[50]  Maria A Oquendo,et al.  Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels , 2001, Biological Psychiatry.

[51]  J. Tiihonen,et al.  Analysis of monoamine oxidase A (MAOA) promoter polymorphism in Finnish male alcoholics , 2002, Psychiatry Research.